Fetalix has been selected to join the Global Health Accelerator, an international programme powered by Startup Braga dedicated to supporting emerging companies in healthcare, biotechnology, and nanotechnology.
The programme provides access to mentorship, industry connections, and research infrastructure aimed at accelerating the development and translation of innovative healthcare technologies. Participation in accelerator programmes of this nature is particularly relevant for biotechnology companies, where scientific innovation must be supported by strategic partnerships, translational planning, and access to multidisciplinary expertise capable of advancing technologies toward clinical and commercial development.
The initiative also brings together institutions including the International Iberian Nanotechnology Laboratory (INL) and the Clinical Academic Center – Braga (2CA-Braga), contributing to a collaborative environment focused on health innovation and translational research.
This selection reinforces Fetalix’s integration within the international healthcare innovation ecosystem.
April 2, 2025
